BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

KIR

Download PDF PDF Version

Image Results

Loading...

Recent Publications on KIR:

Pubmed Logo
Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells.
Killer Ig-like receptor (KIR) expression is mostly restricted to NK cells...
1st July, 2008
Kathleen B. and Mason I. Lowance Center for Human Immunology, Emory J Leukoc Biol. 2008 Jun 27;.
DOI Direct Link
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK cell repertoires towards a balance of missing-self response.
Variegated expression of six inhibitory HLA class I-specific receptors on...
28th June, 2008
Structural Biology, Stanford University School of Medicine, Stanford, CA, Blood. 2008 Jun 26;.
DOI Direct Link
Ligand independent exhaustion of Killer immunoglobulin-like receptor+ CD8+ T cells in HIV-1 infection.
Virus-specific-CD8+ T cells play a central role in the control of viral...
27th June, 2008
Partners AIDS Research Center, Massachusetts General Hospital, Harvard J Virol. 2008 Jun 25;.
DOI Direct Link
High allelic polymorphism, moderate sequence diversity and diversifying selection for B-NK but not B-lec, the pair of lectin-like receptor genes in the chicken MHC.
We previously characterised the C-type lectin-like receptor genes B-NK and...
25th June, 2008
Immunology, Institute for Animal Health, Compton, Berkshire, RG20 7NN, UK, Immunogenetics. 2008 Aug;60(8):461-75. Epub 2008 Jun 24.
DOI Direct Link
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.
Inhibitory killer Ig-like receptors (KIR), expressed by human Natural...
25th June, 2008
U753, INSERM, Villejuif, France. Blood. 2008 Jun 23;.
DOI Direct Link

View more research publications.

BioNews Results for KIR:

RSS Logo
BioPortfolio Logo
Elevated IOP After Cataract Surgery
CRS Today:  Jul 10 2008 8:04PM Matching: kir

KIR Clinical Trials:

Clinical Trials Logo
An Open-Label, Dose-Escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
Refractory Multiple Myeloma
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Leukemia;   Lymphoma
Donor Natural Killer Cell Infusion in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Leukemia;   Myelodysplastic Syndromes
Laboratory-Treated Donor Natural Killer Cells and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Recurrent and/or Metastatic Ovarian Cancer
Ovarian Cancer
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Congenital Hyperinsulinism

View more trials.

KIR Patents:

USPTO Logo
US Patent No.Title
7005191 Oxidation resistant coatings for ultra high temperature transition metals and transition metal alloys
7067625 Isolated TWIK-1 potassium channel proteins
7074409 Polypeptides having a triggering NK activity and biological applications
7074896 Recombinant soluble Fc receptors
7087388 Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets

View more patents.

Companies working in the area of KIR from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

OncoImmunin Incorporated

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued two U.S. patents on its proprietary design for protease inhibitors and fluorogenic...
www.phiphilux.com/        View full profile
Thumbshot

Inspire Pharmaceuticals

Inspire discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms of mucosal hydration and mucociliary clearance, as well as other non...
www.inspirepharm.com/        View full profile
Thumbshot

Kirkegaard & Perry Laboratories Incorporated

Kirkegaard & Perry Laboratories (KPL, Gaithersburg, MD) was founded in 1979 as the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in...
www.kpl.com/        View full profile
Thumbshot

View more KIR related companies.

BioPortfolio Ltd. offers e-mail and postal lists for KIR scientists - we have details of around 188 individuals working on KIR .


This page has been viewed 130 times
Recent Search Terms used to find this page: anti kir 1-7f9 for myeloma | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for KIR across BioPortfolio, or bestselling KIR books or recently published KIR books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional